Biote Corp. Class A Common Stock

BTMDNASDAQUSD
2.22 USD
0.03 (1.33%)AT CLOSE (11:59 AM EDT)
2.23
0.01 (0.23%)
POST MARKET (AS OF 07:05 PM EDT)
Post Market
AS OF 07:05 PM EDT
2.23
0.01 (0.23%)
🔴Market: CLOSED
Open?$2.25
High?$2.32
Low?$2.22
Prev. Close?$2.25
Volume?152.2K
Avg. Volume?295.4K
VWAP?$2.26
Rel. Volume?0.52x
Bid / Ask
Bid?$1.90 × 100
Ask?$2.54 × 100
Spread?$0.64
Midpoint?$2.22
Valuation & Ratios
Market Cap?72.1M
Shares Out?32.0M
Float?15.4M
Float %?46.3%
P/E Ratio?2.67
P/B Ratio?-1.23
EPS?$0.84
Dividend?2.40%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.22Adequate
Quick Ratio?0.79Weak
Cash Ratio?0.54Adequate
Debt/Equity?-1.83Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
2.7CHEAP
P/B?
-1.23CHEAP
P/S?
0.38CHEAP
P/FCF?
2.6CHEAP
EV/EBITDA?
4.0CHEAP
EV/Sales?
0.81CHEAP
Returns & Efficiency
ROE?
-46.2%WEAK
ROA?
25.1%STRONG
Cash Flow & Enterprise
FCF?$28.3M
Enterprise Value?$155.0M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
Employees
223
Market Cap
72.1M
Industry
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Listed
2022-05-27
Address
1875 W. WALNUT HILL LN #100
IRVING, TX 75038
Phone: 972-486-9346